- Product Details
Keywords
- 4-Chlorocarbonylphenylboronic anhydride
- 332154-57-1
- C7H6BClO3
Quick Details
- ProName: 4-Chlorocarbonylphenylboronic anhydrid...
- CasNo: 332154-57-1
- Molecular Formula: C7H6BClO3
- Appearance: Solid
- Application: intermediate
- DeliveryTime: in stock
- PackAge: drums
- Port: Shanghai
- ProductionCapacity: 30 Metric Ton/Month
- Purity: 99%
- Storage: Sealed\dry
- Transportation: Sea, air and courier
- LimitNum: 1 Gram
Superiority
Product Name: (4-CHLOROCARBONYLPHENYL)BORONIC ANHYDRIDE
Synonyms: p-Chlorocarbonylphenylboronic Acid;Boronic acid, B-[4-(chlorocarbonyl)phenyl]-;4-Chlorocarbonylphenylboronic boronic acid;(4-CHLOROCARBONYLPHENYL)BORONIC ANHYDRIDE;4-BORONOBENZOYL CHLORIDE;Boronic acid, [4-(chlorocarbonyl)phenyl]- (9CI);4-Chlorocarbonylbenzeneboronic anhydride, tech. 90%;(4-carbonochloridoylphenyl)boronic acid
CAS: 332154-57-1
MF: C7H6BClO3
MW: 184.38
EINECS:
Mol File: 332154-57-1.mol
(4-CHLOROCARBONYLPHENYL)BORONIC ANHYDRIDE Structure
(4-CHLOROCARBONYLPHENYL)BORONIC ANHYDRIDE Chemical Properties
Melting point >300℃
Boiling point 350.9±44.0 °C(Predicted)
density 1.39±0.1 g/cm3(Predicted)
pka 7.08±0.10(Predicted)
Safety Information
Hazard Codes Xn
Risk Statements 20/21/22-36/37/38
Safety Statements 26-36
Details
Product Name: (4-CHLOROCARBONYLPHENYL)BORONIC ANHYDRIDE
Synonyms: p-Chlorocarbonylphenylboronic Acid;Boronic acid, B-[4-(chlorocarbonyl)phenyl]-;4-Chlorocarbonylphenylboronic boronic acid;(4-CHLOROCARBONYLPHENYL)BORONIC ANHYDRIDE;4-BORONOBENZOYL CHLORIDE;Boronic acid, [4-(chlorocarbonyl)phenyl]- (9CI);4-Chlorocarbonylbenzeneboronic anhydride, tech. 90%;(4-carbonochloridoylphenyl)boronic acid
CAS: 332154-57-1
MF: C7H6BClO3
MW: 184.38
EINECS:
Mol File: 332154-57-1.mol
(4-CHLOROCARBONYLPHENYL)BORONIC ANHYDRIDE Structure
(4-CHLOROCARBONYLPHENYL)BORONIC ANHYDRIDE Chemical Properties
Melting point >300℃
Boiling point 350.9±44.0 °C(Predicted)
density 1.39±0.1 g/cm3(Predicted)
pka 7.08±0.10(Predicted)
Safety Information
Hazard Codes Xn
Risk Statements 20/21/22-36/37/38
Safety Statements 26-36